|
Post by otherottawaguy on Jun 12, 2014 14:48:13 GMT -5
|
|
|
Post by otherottawaguy on Jun 12, 2014 10:06:34 GMT -5
manmade:
Can't read the highlights, had to cut and past to notepad in order to read the following. Too bad there isn't a reference footnote avail.
OOG
New Insulins, Delivery Methods, and Monitoring Technologies Twonewultralong-actinginsulins,insulindegludecandLY2605541, areundergoingtestinginphase3clinicaltrialsand,comparedwith glargine, show similar efficacy but less hypoglycemia with daily in- jections in patients with type 2 diabetes. 91-93 Technosphere insu- lin, a new inhaled formulation, has been approved by the US Food and Drug Administration. Insulin is available in prefilled pens in which the dose is dialed in and needles are changed between doses. These pens are being used increasingly because of their convenience, greater accuracy, andpatientpreference. 94 Theirmajorlimitationishigherpatientcost andinsurancecoverage,althoughtotalannualizedhealthcostsmay belowerandadherenceimproved. 95,96 Patientsin23of24studies preferred pens to syringes, citing ease of use, acceptability, conve- nience, and perceived efficacy. 97 Continuousinsulininfusion(pump)therapyinpatientswithtype 2 diabetes can be considered in those with severe insulin resis- tanceandpoorcontrol. 98,99 Newermechanicalpatchpumpsarecur- rentlybeingtestedinrandomizedtrials. 99 Continuousglucosemoni- toring has been recommended in patients with type 2 diabetes to detect nocturnal hypoglycemia, increased insulin resistance in the morning(dawnphenomenon),postprandialhyperglycemia,andhy- poglycemic unawareness and can be used during major regimen changes. 100
|
|
|
Post by otherottawaguy on Jun 10, 2014 22:10:16 GMT -5
To give a quick summary of my deep under standing of options strategies (would probably fill a thimble). I have been watching the shares increase, but have been watching the Jan 5 Calls growing or retracting at a rate of 50% more than the daily gains of the common shares. The Jan 7 Calls have been growing at twice than the rate of the CS. e.g. Common up 4%, Jan 2015 5s up 6%, Jan 2015 7s up 8%.
As soon as the rate of growth between the options and shares starts to converge does it then make sense to sell the options and buy back the shares in the market, or sell enough to cover the strike price? All while maximizing the share count you get to keep?
OOG
|
|
|
Post by otherottawaguy on Jun 10, 2014 9:01:34 GMT -5
Thought with a title like that, it was going to be something about Jack or Diane...
Something like this to the tune of Mellencamps Jack & Diane:
Little ditty about Alfred Mann, American ingenuity at work in the heartland, Affrezza going to be NASDAQ star, Share price is going to go very far.
....
please feel free to add more
OOG
|
|
|
Post by otherottawaguy on Jun 5, 2014 10:34:13 GMT -5
Quoting the great Bill Cosby, "Roland and the Rooolllleeeee Coaster". Gaddang that was fun for sitting right up front on the ride, wonder how tight they were holding the bar as the tracks ran out. I don't believe it, I don't believe it,...you could hear as their stops were taken out.
OOG
|
|
|
Post by otherottawaguy on Jun 4, 2014 16:31:07 GMT -5
I'm resurrecting this thread to show that if you look at the map now, MannKind no longer has a booth. What might be of interest, is that Novo's foot print has just expanded into what used to be the space occupied by MNKD if my memory serves me correctly. I believe that they had the top right corner of booth 1406 that is no longer separate from Novo.
Coincidence or just expansion into the void due to proximity? I'll leave that one up for further discussion.
OOG
|
|
|
Post by otherottawaguy on Jun 4, 2014 8:52:10 GMT -5
MannKind Corp. (MNKD) -NasdaqGM
10.00 Up 0.49(5.15%) 9:49AM EDT - Nasdaq Real Time Price
|
|
|
Post by otherottawaguy on Jun 3, 2014 16:10:51 GMT -5
I took some off the table at the 6.25 mark....(dumbass). Was looking for a quick dash in and out else where. Got back and crap, the train had left the station.
OOG
|
|
|
Post by otherottawaguy on May 27, 2014 8:25:44 GMT -5
ADA conference is 13-17 June, guess they are still holding their "No Partner, No Approval, No need to be there" line from the Quarterly call.
MannKind to Present at Upcoming Conferences
VALENCIA, Calif., May 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at upcoming conferences. Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 2:30 pm (ET) in New York, New York.
Goldman Sachs 35th Annual Global Healthcare Conference on Thursday, June 12, 2014 at 11:20 am (PT) at the Terranea Resortin Rancho Palos Verdes, California.
Wells Fargo 2014 Healthcare Conference on Tuesday, June 17, 2014 at 10:00 am (ET) at the InterContinental in Boston, Massachusetts.
|
|
|
Post by otherottawaguy on May 15, 2014 8:24:04 GMT -5
OPA...
|
|
|
Post by otherottawaguy on May 9, 2014 15:10:25 GMT -5
|
|
|
Post by otherottawaguy on May 2, 2014 12:51:12 GMT -5
Need to craft a question that sounds on the surface to be a simple yes/no but that actually gives an unintended answer in their body language.
|
|
|
Post by otherottawaguy on Apr 30, 2014 14:43:16 GMT -5
Try trading in and out of 10k shares for a 2% return each time. Should make it interesting for you if your out and the price keeps rising like it is today. Really interesting...
OOG
|
|
|
Post by otherottawaguy on Apr 22, 2014 15:19:46 GMT -5
Guess my question comes in the form of two explicit question then.
Where are the GAPs upwards and downwards from here? How are you ascertaining these values?
OOG
|
|
|
Post by otherottawaguy on Apr 22, 2014 13:08:34 GMT -5
I see many references to filling of gaps in the numerous messsage boards (MNKD & EXEL). Can someone tell me are these just "guesses" or is there some sort of chart that one can look at that has some sort of methodolgy driving it.
Just looking for general information on the subject (or a link) if anyone has the time to spare.
Enjoy the day,
OOG
|
|